Escalon Medical CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Escalon Medical Corp. announced a 5.7% increase in net revenue for the fiscal year ended June 30, 2026, driven by strong performance in Sonomed products and services, alongside a significant gain from the sale of its AXIS software business.
OQB
Escalon Medical Corp. reported a slight increase in net revenue for fiscal year 2025, but auditors continue to express substantial doubt about the company's ability to continue as a going concern.
OQB
Escalon Medical Corp.'s annual report reveals a slight revenue decrease and ongoing concerns about the company's ability to continue as a going concern.